Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.
N Engl J Med
; 386(9): 892-894, 2022 03 03.
Article
in English
| MEDLINE | ID: covidwho-1721731
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Infant, Premature
/
Respiratory Syncytial Virus Infections
/
Antibodies, Monoclonal, Humanized
/
Infant, Premature, Diseases
Type of study:
Randomized controlled trials
Topics:
Long Covid
Limits:
Humans
/
Infant
/
Infant, Newborn
Language:
English
Journal:
N Engl J Med
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS